Group One Trading’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.7K Sell
19,700
-29,100
-60% -$57.5K ﹤0.01% 5639
2026
Q1
$92.7K Sell
48,800
-16,300
-25% -$28K ﹤0.01% 4804
2025
Q4
$104K Buy
65,100
+32,800
+102% +$68.8K ﹤0.01% 4980
2025
Q3
$75.3K Buy
32,300
+15,900
+97% +$30K ﹤0.01% 5593
2025
Q2
$20.7K Sell
16,400
-1,300
-7% -$1.28K ﹤0.01% 6246
2025
Q1
$16.2K Buy
17,700
+5,400
+44% +$7.02K ﹤0.01% 5957
2024
Q4
$19.6K Sell
12,300
-5,800
-32% -$11.7K ﹤0.01% 5700
2024
Q3
$35.5K Buy
18,100
+17,500
+2,917% +$35.8K ﹤0.01% 4880
2024
Q2
$984 Sell
600
-10,500
-95% -$33.6K ﹤0.01% 6362
2024
Q1
$57.1K Buy
11,100
+10,800
+3,600% +$66.6K ﹤0.01% 4607
2023
Q4
$1.72K Sell
300
-19,700
-99% -$97.4K ﹤0.01% 6869
2023
Q3
$95.6K Buy
20,000
+19,600
+4,900% +$122K ﹤0.01% 4501
2023
Q2
$1.7K Buy
400
+200
+100% +$899 ﹤0.01% 7131
2023
Q1
$1.06K Sell
200
-1,100
-85% -$6.85K ﹤0.01% 6778
2022
Q4
$8.16K Buy
+1,300
New +$11.6K ﹤0.01% 6111

Other funds holding CRBU

Group One Trading's CRBU Position: Q2 2026 in Review

Group One Trading opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 5,416 shares worth $9.53K. The stake represents ﹤0.01% of the portfolio and ranks #6424 among its holdings. This is a return to the name: Group One Trading previously reported a position in CRBU as recently as Q3 2025.

Group One Trading first reported a position in CRBU in Q2 2022 and has held it in 12 quarters since. The position peaked at $32.7K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Group One Trading held 5,416 shares of Caribou Biosciences worth $9.53K as of Q2 2026.
  • Caribou Biosciences was a new Group One Trading position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6424 holding.
  • Group One Trading first reported a position in Caribou Biosciences in Q2 2022 and has held it in 12 quarters since.
  • Group One Trading's Caribou Biosciences position peaked at $32.7K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.